LINC01303: A Non-Protein Coding RNA Molecule with Potential Applications

Target Name: LINC01303

NCBI ID: G101927780

LINC01303

Other Name(s): Long intergenic non-protein coding RNA 1303, transcript variant 1 | long intergenic non-protein coding RNA 1303

LINC01303: A Non-Protein Coding RNA Molecule with Potential Applications

LINC01303 is a non-protein coding RNA (ncRNA) molecule that has been identified using RNA sequencing (RNA-seq) experiments. It is located within the gene cluster of the protein coding gene LINC01288 and has a length of 292 nucleotides.

The function of LINC01303 is not well understood, but it is known to play a role in the regulation of gene expression. LINC01303 is expressed in a variety of tissues and cells, including the brain, heart, and testes, and has been shown to be involved in the regulation of gene expression in these tissues.

One potential function of LINC01303 as a drug target is its involvement in the regulation of cellular processes that are relevant to drug development, such as cell growth, apoptosis, and inflammation. LINC01303 has been shown to be involved in the regulation of cell cycle progression, and it has been shown to play a role in the regulation of the cell apoptosis pathway.

In addition to its potential role in drug development, LINC01303 may also be a useful biomarker for the diagnosis and prognosis of certain diseases. For example, LINC01303 has been shown to be expressed in the brains of individuals with Alzheimer's disease, and it has been shown to be involved in the regulation of the production of neurodegeneration.

Overall, the function and potential applications of LINC01303 make it an interesting candidate for further study as a drug target or biomarker. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1303

The "LINC01303 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01303 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets